Mori Hamada advised Bain Capital on its JPY 510 billion (approx. USD 3.3 billion) acquisition of Mitsubishi Tanabe Pharma Corporation from Mitsubishi Chemical Group Corporation.
The Mori Hamada team was led by partners Hajime Tanahashi, Rintaro Shinohara and Yusuke Takamiya, and counsel Hiroko Kasama.
Period
February, 2025
Practices
People
Related Cases
My Page
Mori Hamada My Page
(Members' Portal)
The firm's “Mori Hamada My Page” service enables gathering and viewing of information on seminars, newsletters, publications, public announcements from government agencies, and other matters all in one centralized portal.
